Halozyme Therapeutics
HALO
Reported
Tuesday, February 18
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 1.16 | 1.26 | 0.10 | 8.62% |
| Revenue | 286M | 298M | 12.3M | 4.29% |
WhatIF - Earnings
EPS Beat Expectations by $0.10
Halozyme Therapeutics (HALO:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything